SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AACR: American Association for Cancer Research

2.

Immunotherapy in Head and Neck Cancer After Failure of Definitive Therapy.

3.

Cancer care crowdfunding increasingly common, but rarely successful

4.

Immunotherapy Is As Safe As Other Cancer Treatments During Pregnancy.

5.

Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot